Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sight Sciences, Inc.SGHT · Entity 5537 | Chief Financial Officer | January 01, 2023 | January 05, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sight Sciences, Inc.
Report date January 01, 2023 · Filed January 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 406,250 |
Reported balance
After 2023-01-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-01-01 · Grant · Acquired 28,100 · Balance 406,250 F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date. F2: Includes 7,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant. |
| Common StockSEC Table I · non-derivative | Direct | 403,359 |
Reported balance
After 2023-01-04 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-01-04 · Tax withholding · Disposed 2,891 · Balance 403,359 F3: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs. F4: Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date.
F2: Includes 7,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant.
F3: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs.
F4: Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2023 Filed Jan 5, 2023 11:30 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Tax withholdingCommon Stock | 2,891 | $12.38 | $35,787.69 |
DisclosureSEC source: 0000899243-23-000829 · doc4.xml · nonDerivative · entry 2 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,359 F3 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs. F4 · price: Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 11:30 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 28,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000829 · doc4.xml · nonDerivative · entry 1 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,250 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date. F2 · balance_after: Includes 7,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant. Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:05 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | PurchaseCommon Stock | 5,000 | $8.28 | $41,400.00 |
DisclosureSEC source: 0000899243-22-018389 · doc4.xml · nonDerivative · entry 1 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,225 F1 · ownership.direct: The Reporting Person previously reported indirect beneficial ownership of 2,219,568 shares of Common Stock held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). Sight Sciences Angels subsequently distributed such shares of Common Stock to its partners, resulting in the Reporting Person directly owning the shares of Common Stock in which he previously had an indirect pecuniary interest. Such change in ownership was exempt from reporting pursuant to Rule 16a-13. Read SEC document |
| May 11, 2022 Filed May 23, 2022 21:44 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0000899243-22-019270 · doc4.xml · derivative · entry 4 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 30,000 shares Expires 2029-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in 48 substantially equal monthly installments beginning on March 18, 2019. Read SEC document |
| May 11, 2022 Filed May 23, 2022 21:44 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Exercise / conversionStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0000899243-22-019270 · doc4.xml · derivative · entry 3 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares on January 23, 2019 and in 36 equal monthly installments thereafter. Read SEC document |
| May 11, 2022 Filed May 23, 2022 21:44 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Exercise / conversionCommon Stock | 30,000 | $0.62 | $18,600.00 |
DisclosureSEC source: 0000899243-22-019270 · doc4.xml · nonDerivative · entry 2 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,000 shares acquired on May 13, 2022 reported on a Form 4 filed on May 17, 2022. Read SEC document |
| May 11, 2022 Filed May 23, 2022 21:44 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Exercise / conversionCommon Stock | 120,000 | $0.35 | $42,000.00 |
DisclosureSEC source: 0000899243-22-019270 · doc4.xml · nonDerivative · entry 1 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,000 shares acquired on May 13, 2022 reported on a Form 4 filed on May 17, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:05 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantStock Option (Right to Buy) · Derivative | 112,400 | $0.00 Strike: $17.52 | $0.00 |
DisclosureSEC source: 0000899243-22-005826 · doc4.xml · derivative · entry 2 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,400 Underlying: Common Stock · 112,400 shares Expires 2032-02-09 F3 · derivative.exercise_date: The options vest and become exercisable in 48 substantially equal monthly installments with the first installment vesting on February 1, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:05 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantRestricted Stock Units · Derivative | 28,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-005826 · doc4.xml · derivative · entry 1 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,100 Underlying: Common Stock · 28,100 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest as to 25% on each of January 1, 2023; January 1, 2024; January 1, 2025 and January 1, 2026. The Restricted Stock Units have no expiration date. F2 · derivative.expiration_date: The Restricted Stock Units vest as to 25% on each of January 1, 2023; January 1, 2024; January 1, 2025 and January 1, 2026. The Restricted Stock Units have no expiration date. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 01:05 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | PurchaseCommon Stock | 10,000 | $18.44 | $184,393.00 |
DisclosureSEC source: 0000899243-21-045876 · doc4.xml · nonDerivative · entry 1 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,229,568 F1 · ownership.nature: These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 00:19 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | ConversionSeries C Redeemable Convertible Preferred Stock · Derivative | 121,725 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-028882 · doc4.xml · derivative · entry 4 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 243,450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 00:19 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | ConversionSeries B Redeemable Convertible Preferred Stock · Derivative | 118,494 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-028882 · doc4.xml · derivative · entry 3 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 236,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 00:19 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | ConversionSeries A Redeemable Convertible Preferred Stock · Derivative | 869,565 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-028882 · doc4.xml · derivative · entry 2 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,739,130 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 00:19 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | ConversionCommon Stock | 2,219,568 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-028882 · doc4.xml · nonDerivative · entry 1 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,219,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.